Maddy summaryThis bill provides overtime pay for Iowa state employees earning under $125,000 annually who are not covered by federal overtime rules (Fair Labor Standards Act). It requires these employees to receive 1.5 times their regular hourly rate for overtime hours worked. The bill mandates that salaries for such employees must be set on an hourly basis, not as an annual salary. This change directly affects non-exempt state workers in positions previously not eligible for overtime under state law.
Sponsored bills
Maddy summaryThis bill increases the maximum unemployment benefits for workers laid off when their employer closes permanently. It raises the cap from 26 to 39 times the individual's weekly benefit amount during a benefit year. This change directly affects workers who lose jobs due to an employer going out of business at their workplace. The policy adjusts the benefit calculation to provide greater financial support in these specific circumstances.
Maddy summarySF 264 creates a Prescription Drug Affordability Board in Iowa to address high prescription drug costs. The board, appointed by the governor with Senate confirmation, will review drug pricing and may recommend upper payment limits for prescription drugs affecting all Iowans, especially patients with illnesses, opioid crisis communities, and healthcare providers. Key provisions require the board to hold public meetings, accept public input, and enforce strict conflict-of-interest rules (e.g., members cannot receive over $5,000 annually from drug manufacturers). The bill establishes this mechanism to review drug costs but does not yet implement price controls.
Maddy summarySF 248 requires Iowa's Department of Health and Human Services (HHS) to include a specific provision in all contracts with qualified residential treatment programs (QRTPs). This provision allows QRTP contractors to reject a placement referral from HHS or juvenile court services if they confirm in writing that they lack the necessary security or support to ensure the safety of either the individual or their staff. The bill also prohibits HHS from including any "no reject, no eject" clause in these contracts, which would force contractors to accept all referrals regardless of safety concerns. This law applies to all new, extended, or renewed QRTP contracts starting on the bill's effective date.
Maddy summarySF 263 amends Iowa's public employee collective bargaining laws. It requires negotiations on pay, hours, safety, and other terms (but excludes retirement systems) and mandates written member consent for union dues deductions. The bill imposes a 12-month ban on union representation after decertification due to legal violations like contempt of court. These changes affect public school teachers, city workers, and other state/local government employees covered by union contracts.
Maddy summarySF 223 appropriates $2.5 million from Iowa's general fund for the 2024-2025 fiscal year to the Department of Health and Human Services (HHS). This funding will be distributed proportionally to nonprofit resettlement agencies that partner with the U.S. Department of State to provide assistance to refugees in Iowa. HHS must distribute the funds within seven days of the bill's enactment to cover resettlement expenses like housing and support services. The bill is procedural, focusing solely on funding allocation without altering refugee policies or eligibility.
Maddy summarySF 188 requires most health insurance plans in Iowa to cover contraceptive drugs, devices, and services without cost-sharing (like copays or deductibles), provided the plan covers other prescription drugs or services. It prohibits insurers from denying coverage, reducing benefits, or penalizing providers for offering contraceptive care, and defines "medical need" to allow doctors to recommend specific contraceptives without extra costs. The law applies to individual and group health plans (including those for public employees) issued or renewed on or after January 1, 2026, but excludes dental, vision, and short-term insurance. Insurers must clearly disclose contraceptive coverage details on their websites and via mail upon request.
Maddy summarySF 185 establishes a state-run retirement savings trust for Iowa workers, automatically enrolling employees (with a 5% default contribution rate) through payroll deductions unless they opt out. It applies to workers in Iowa who are subject to state wage withholding, with employers of 5+ employees required to facilitate payroll deductions but not to contribute. The trust operates under federal guidelines, prohibits employer ownership of contributions, and includes provisions for annual account reports, confidentiality of participant data, and explicit disclaimers that the state does not guarantee returns or cover losses.
Maddy summaryThis Iowa bill (SF 210) requires health licensing boards to check national databases (including child abuse and sex offender registries) before issuing licenses, denying licenses if matches are found. It mandates creation of a public online database tracking disciplinary actions, especially for sexual misconduct, substance use, or medical malpractice. The bill requires immediate license suspension for sexual misconduct or assault allegations and a 10-year waiting period plus treatment for those with founded cases. It directly affects all health professionals (doctors, nurses, etc.) seeking or holding licenses in Iowa by tightening background checks, reporting duties, and disciplinary timelines.
Maddy summarySF 209 requires most health insurance plans in Iowa to cap out-of-pocket costs for prescription insulin at $25 per prescription (for up to a 31-day supply). It directly affects people with diabetes who have insurance covering insulin, limiting their cost-sharing for four types: rapid-acting, short-acting, intermediate-acting, and long-acting insulin. The bill sets this $25 maximum for plans issued or renewed after January 1, 2026, while excluding certain insurance types like Medicare supplements. Insurers may lower costs below $25 but cannot exceed this cap for covered insulin drugs.